Search

Professor Mark Middleton

Medical oncology

  • Fee assured
Overview

Specialises in

  • Skin

About me

Professor Middleton trained at the Universities of Cambridge and Oxford, qualifying in 1991. He undertook oncology training at the Christie Hospital and Paterson Institute in Manchester. He has an international reputation for the care of patients with melanoma, participating in numerous clinical trials and contributing to the development of new medicines such as vemurafenib and ipilimumab. Prof Middleton is based at Oxford University Hospitals NHS Trust where he is also responsible for the Early Phase Cancer Trials Unit.

Areas of interest

Treatment of melanoma, including with targeted agents, chemotherapy and immunotherapy. Cancer drug development and experimental therapeutics.

Medical secretaries

About me
My qualifications & training
Consultant's practices
Information for healthcare professionals

Information for healthcare professionals (Bupa patients only, last 12 months)

Procedures completed

  • AA844

    Clinical supervision and planning for delivery of chemotherapy cycle in the member's home 1-28 days - (5-50)

  • AA842

    Clinical supervision and planning for delivery of chemotherapy cycle in the member's home 1-14 days - (5-50)

  • AA843

    Clinical supervision and planning for delivery of chemotherapy cycle in the member's home 1-21 days - (5-50)

Edit details Print page

The information contained on Finder is submitted by consultants, therapists and healthcare services, and these third parties declare it to be correct and compliant with their relevant regulatory bodies' standards and codes of conduct. We're unable to guarantee the accuracy of all of the information provided.

You can find out more about the information on Finder and our website terms of use here.